Learn how to build decision-grade disease registries that turn real-world data into reliable evidence for regulatory, clinical, and market-access decisions.
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
- What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes
- AI Governance Is Becoming A Competitive Edge In Trials
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?
- From 73% Noncompliant To 2.4%: Building A Compliance Office
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Building A Scalable Oncology Engine In A Dynamic Market
Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.
-
Drive Innovation In Clinical Trial Software: 3 Trends You Need To Watch
The clinical trial landscape is undergoing a transformative shift as technology increasingly shapes study design and execution. Explore three pivotal trends that are driving this evolution.
-
The Future Of Remote Patient Monitoring In Decentralized Clinical Trials
Remote Patient Monitoring (RPM) is not just an innovation—it's a catalyst redefining how clinical research is conducted in the digital age.
-
AI‑Readiness Checklist: Is Your Clinical Data Environment Ready?
AI impact depends on solid data practices, good governance, and team alignment. This piece highlights what to assess and how organizations can build readiness for future initiatives.
-
How Digital Therapeutics Tools Interact To Improve Patient Care
This comprehensive overview illustrates the intersection between prescription digital therapeutics, digital health tools, and decentralized clinical trials in a remote care setting.
-
Navigating The eCOA Vendor Landscape In 2025
This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.
-
Mitigating The Risks Of Long-Term Oncology eCOA Clinical Trials
This article digs into the specific complexities of long oncology clinical trials and describes relevant solutions to manage the risks regarding patient compliance, clinical project teams, and clinical sites.
-
Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology
Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.
-
6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies
Real-world data (RWD) is transforming colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.
-
Streamlining Trials With eConsent And EDC
Integrating eConsent with EDC streamlines clinical workflows, improves data accuracy, and enhances patient engagement by creating a unified, compliant system for consent and trial data management.
RECENT NEWSLETTERS
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps